New Jersey

Psychedelic trials in New Jersey

18 registered trials has a study site in New Jersey, and 1 is recruiting now.

18

Trials with a site here

1

Recruiting

14

Facilities

Open now

Recruiting in this state

Trial	Status	Phase	Substance	Sites
A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive DisorderNCT06793397 · Cybin IRL Limited	Recruiting	Phase 3	psilocybin	68

Facilities

Where the research happens in New Jersey

Facility	City	Trials
Hassman Research Institute	Berlin	5
Bio Behavioral Health	Toms River	3
Princeton Medical Institute	Princeton	3
Clinical Site 101	Toms River	2
Global Medical Institutes, Princeton Medical Institute	Princeton	1
Cenexel HRI	Berlin	1
Global Medical Institutes, LLC; Princeton Medical Institute	Princeton	1
Juvenile Bipolar Research Foundation	Maplewood	1
Individual homes of subjects	Not Predetermined	1
GMI - Princeton Medical Institute	Princeton	1
Clinical Site 148	Toms River	1
Clinilabs Drug Development Corporation	Eatontown	1
Novartis Investigative Site	Berlin	1
Cooper University Hospital	Camden	1

Stay told

When a trial opens in New Jersey

All trials

Every trial with a New Jersey site

Trial	Status	Phase	Substance	Sites
A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive DisorderNCT06793397 · Cybin IRL Limited	Recruiting	Phase 3	psilocybin	68
"A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder"NCT06564818 · Cybin IRL Limited	Active, not recruiting	Phase 3	psilocybin	45
Efficacy, Safety, and Tolerability of COMP360 in Participants With TRDNCT05624268 · COMPASS Pathways	Completed	Phase 3	psilocybin	40
Efficacy, Safety, and Tolerability of Two Administrations of COMP360 in Participants With TRDNCT05711940 · COMPASS Pathways	Active, not recruiting	Phase 3	psilocybin	116
A Phase 3 Trial of MM120 for Generalized Anxiety Disorder (Panorama)NCT06809595 · Definium Therapeutics US, Inc.	Active, not recruiting	Phase 3	lsd	36
A Phase 3 Trial of DT120 for Major Depressive Disorder (Emerge)NCT06941844 · Definium Therapeutics US, Inc.	Active, not recruiting	Phase 3	lsd	22
Psilocybin for Major Depressive Disorder (MDD)NCT06308653 · Usona Institute	Active, not recruiting	Phase 3	psilocybin	29
A Phase 3 Trial of DT120 for Generalized Anxiety Disorder (Voyage)NCT06741228 · Definium Therapeutics US, Inc.	Active, not recruiting	Phase 3	lsd	34
Intranasal Ketamine In the Treatment of Pediatric Bipolar DisorderNCT01504659 · Juvenile Bipolar Research Foundation	Terminated	Phase 2 / Phase 3	ketamine	4
A Study of CLE-100 (Oral Esketamine) as an Adjunctive Treatment to Standard Antidepressants for Major Depressive DisorderNCT06340958 · Clexio Biosciences Ltd.	Completed	Phase 2	ketamine	23
A Study of Psilocybin for Major Depressive Disorder (MDD)NCT03866174 · Usona Institute	Completed	Phase 2	psilocybin	11
A Dose-Finding Study of MM120 (LSD D-Tartrate) for the Treatment of Anxiety SymptomsNCT05407064 · Definium Therapeutics US, Inc.	Completed	Phase 2	lsd	22
A Study of CLE-100 (Oral Esketamine) in Addition to Standard Antidepressant Drug for Major Depressive Disorder - CLEO StudyNCT04103892 · Clexio Biosciences Ltd.	Completed	Phase 2	ketamine	46
A Study of Ketamine in Patients With Treatment-resistant DepressionNCT01627782 · Janssen Research & Development, LLC	Completed	Phase 2	ketamine	13
A Randomized, Placebo-Controlled, Double-Blind Study to Assess Safety and Efficacy of PCN-101 in TRDNCT05414422 · Perception Neuroscience	Completed	Phase 2	ketamine	21
A Study of a Psilocybin Analog (CYB003) in Healthy Participants With and Without Major Depressive DisorderNCT05385783 · Cybin IRL Limited	Completed	Phase 1 / Phase 2	psilocybin	3
Proof of Concept Study Evaluating the Efficacy and Safety of MIJ821 in Patients With Treatment-resistant DepressionNCT03756129 · Novartis Pharmaceuticals	Completed	Phase 2	ketamine	12
TIMBER Psychotherapy and Ketamine Single Infusion in Chronic PTSDNCT02766192 · The Cooper Health System	Unknown status	Not applicable	ketamine	1

Site locations from ClinicalTrials.gov API v2, data build 2026-08-25.

Elsewhere

Other states